首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
【24h】

A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression

机译:激活诱导的胞苷脱氨酶表达后,T细胞和B细胞之间的体细胞超突变的靶标选择受到类似的调节

获取原文
获取原文并翻译 | 示例
           

摘要

Activation-induced cytidine deaminase (AID) is essential for somatic hypermutations (SHM) and class switch recombination. Over-expression of AID in non-B cells can induce SHM in artificial constructs inserted in various loci in the genome. AID overexpres-sion was thus proposed to introduce mutations in a wide variety of genes with little specificity. We previously showed that AID transgenic mice developed T cell lymphomas in which the variable region β genes of the T cell receptor and c-myc were mutated as frequently as SHM in activated B cells. To understand the target specificity of SHM in AID-expressing T lymphomas, we sequenced six oncogenes (c-myc, pim1, p53, atm. tgfbr-2, and k-ras) and two genes (cd4 and cd5) that are actively transcribed in T lymphomas. SHM was found only in c-myc, pim1, cd4, and cd5, which share the E47 binding motif in the enhancer/promoter. The rest that are not mutated in B cells were not mutated in AID-induced T lymphomas either, although they are transcribed in T and B cells. Comparison of several features of SHM, including selection of targets and mutation distribution, suggests that the regulatory mechanism of SHM is similar between T and B cells. SHM base specificities in the CD4 and CD5 genes were biased to AT, indicating that the preference of target bases of the mutations generated by overexpression of AID is not always GC bases but variable between target genes.
机译:激活诱导的胞苷脱氨酶(AID)对于体细胞超突变(SHM)和类别开关重组至关重要。非B细胞中AID的过表达可以在插入基因组各个基因座的人工构建物中诱导SHM。因此提出了AID过表达以很少的特异性在多种基因中引入突变。我们以前表明,AID转基因小鼠发展了T细胞淋巴瘤,其中T细胞受体和c-myc的可变区β基因在激活的B细胞中的突变频率与SHM一样高。为了了解SHM在表达AID的T淋巴瘤中的靶特异性,我们对六个转录活性基因(c-myc,pim1,p53,atm。tgfbr-2和k-ras)和两个基因(cd4和cd5)进行了主动转录在T淋巴瘤中。仅在c-myc,pim1,cd4和cd5中发现了SHM,它们在增强子/启动子中具有E47结合基序。尽管在T细胞和B细胞中转录,但未在B细胞中突变的其余部分在AID诱导的T淋巴瘤中也未发生突变。比较SHM的几个特征,包括靶标的选择和突变分布,表明T细胞和B细胞之间SHM的调控机制相似。 CD4和CD5基因中的SHM碱基特异性偏向AT,这表明由AID过表达产生的突变的目标碱基的偏好并不总是GC碱基,而是在目标基因之间可变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号